(Investigator site)

London, Ontario N6A 5W9

0 studies enrolling now · 3 studies all time

What they study most

Clostridioides Difficile Infection, Clostridium Difficile Infection, Ulcerative Colitis

Studies at this site

• ECOSPOR III - SER-109 Versus Placebo in the Treatment of Adults With Recurrent Clostridium Difficile Infection — Completed
• ECOSPOR IV: An Open-Label Study Evaluating SER-109 in Recurrent Clostridioides Difficile Infection — Completed
• A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis — Stopped early